§ Funding Round
Series B funding round for NOCD raising $33M in September 2021
Series B funding round for NOCD raising $33M in September 2021
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
Advent Life Sciences | — | — |
Draper Associates | — | — |
| Organization | — | |
General Catalyst | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Angel | curtis chambers | |
| Organization | — | |
| Organization | — | |
jon limLEAD | Angel | jon lim |
| Organization | — | |
| Angel | daniel van den bergh |
This company has completed 5 funding rounds. Current round is highlighted.
Total Raised
$84M
Top Valuation
-
NOCD raised $33M in a Series B round.
The round was announced on 09/01/21.
The round was led by jon lim.
